#19 The Power of Partnerships for Drug Discovery. Anmol Nagpal.

Anmol Nagpal is the founder and CEO of Nospharma, a pre-clinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders. Prior to this, Anmol was a founder in residence at District 3 where he coached several early-stage founders and worked with them on their venture’s strategy plans. In this episode, Anmol shares how he spun out research from McGill university into a biotech company tackling rare genetic disorders including Fragile X syndrome. It’s a candid conversation covering licensing, fundraising, partnerships to accelerate growth and early stage hurdles. Tune in to hear what it takes to bring a therapy from research to patients. Recorded live at the 'Healthtech Social: Catalyst’ event on April 1 in Montreal.